Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone

Currently, the national malaria control programme (NMCP) of Sierra Leone recommends artesunate–amodiaquine (ASAQ) and artemether–lumefantrine (AL) as first- and second-line treatment for uncomplicated malaria, respectively, and artesunate + sulfadoxine–pyrimethamine (SP) for intermittent preventive...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Samuel J., Kamara, Anitta R.Y., Sahr, Foday, Samai, Mohamed, Swaray, Alpha S., Menard, Didier, Warsame, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058284/
https://www.ncbi.nlm.nih.gov/pubmed/29932931
http://dx.doi.org/10.1016/j.actatropica.2018.06.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058284/
https://www.ncbi.nlm.nih.gov/pubmed/29932931
http://dx.doi.org/10.1016/j.actatropica.2018.06.016

Ejemplares similares